Bruk av amniocenteser og chorionbiopsier i Norge
DOI:
https://doi.org/10.5324/nje.v7i1.351Abstract
SAMMENDRAG
Invasiv prenatal diagnostikk i form av amniocentese (fostervannsprøve) og chorionbiopsi (morkakeprøve)
utføres i ca. 2% av alle svangerskap i Norge per år. Dette er betydelig færre undersøkelser enn
hva som utføres i de andre nordiske land. De fleste får utført amniocentese pga. høy maternell alder
(aldersindikasjon) som her i landet er
≥ 38 år ved fødselstermin. Chorionbiopsi er forbeholdt kvinner
med kjente arvelige lidelser i familien, dvs. kvinner med høy risiko for å få et affisert foster. De undersøkelser
som foreligger over svangerskapsutfall samt forekomst av komplikasjoner etter amniocentese
og chorionbiopsi er hovedsakelig utført i andre land på kvinner med generelt lavere risiko (
≥ 35 år) enn
for dem som får utført invasiv prenatal diagnostikk i Norge. Pga. vår restriktive praksis kan ikke disse
resultatene uten videre overføres til Norge. Vi mangler eksakte data over svangerskapsutfall og evt.
komplikasjoner etter disse undersøkelsene i en norsk populasjon.
Haugen G, van der Hagen CB.
The use of amniocentesis and chorionic villus sampling in Norway.
Nor J Epidemiol
ENGLISH SUMMARY
Amniocentesis or chorionic villus sampling are performed in about 2% of all pregnancies in Norway
which is far less than in the other Nordic countries. Most of the amniocenteses are performed due to
advanced maternal age. In Norway this is defined as maternal age
≥ 38 years at term. Couples with
known chromosomal aberrations or genetic diseases in their families, i.e. women at a high risk of having
an affected fetus, are offered chorionic villus sampling. Earlier studies on complications and pregnancy
outcome following amniocentesis or chorionic villus sampling have been performed in other countries
mainly on women at a lower risk (
≥ 35 years) than for the women having such tests in Norway. We do
not have data on pregnancy outcome and possible complications following amniocentesis and chorionic
villus sampling in a Norwegian population.
1997; 7 (1): 29-32.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
